The Prognostic Value of Tumor Mitotic Rate and Other Clinicopathologic Factors in Patients with Locoregional Recurrences of Melanoma

Rajmohan Murali; Marc Moncrieff; Jonathan Hong; Caroline Cooper; Meena Shingde; David Samuel; John F. Thompson; Richard A Scolyer

doi:10.1245/s10434-010-1078-0

Related publications

Article2011

24. The prognostic value of mitotic rate in recurrent melanoma

Rajmohan Murali, Marc Moncrieff, Jonathan Hong, Caroline Cooper, Meena Shingde, David Samuel, John F. Thompson, Richard A Scolyer

Article2019

The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study

Norbertus A. Ipenburg, Serigne Lo, Ricardo E. Vilain, Lodewijka H. J. Holtkamp, James S. Wilmott, Omgo E. Nieweg, John F. Thompson, Richard A Scolyer

Article2004

The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up

Anne Brecht Francken, Helen M. Shaw, John F. Thompson, Seng‐Jaw Soong, Neil A. Accortt, Manuela F. Azzola, Richard A Scolyer, G. W. Milton, William H. McCarthy, Marjorie H. Colman, Vincent J. McGovern

Article2003

Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma

Manuela F. Azzola, Helen M. Shaw, John F. Thompson, Seng-Jaw Soong, Richard A Scolyer, Geoffrey F. Watson, Marjorie H. Colman, Yuting Zhang

Article2020

Quantifying the additional prognostic value of sentinel lymph node status over established clinicopathologic primary tumor features for predicting survival outcomes in melanoma patients.

Serigne Lo, Mary‐Ann El Sharouni, Karijn P.M. Suijkerbuijk, Tasnia Ahmed, Witkamp Arjen, Anne Ε. Cust, V. Sigurdsson, P. J. van Diest, Richard A Scolyer, Carla H. van Gils, John F. Thompson